Atherogenics' drug, AGI-1067, is aimed at reducing heart attacks on top of existing cholesterol-lowering drugs, like Lipitor, Zocor and AstraZeneca's own Crestor.
FORBES: A Heart-Stopping Deal
应用推荐
模块上移
模块下移
不移动